← 返回首页
美国 · 平台与数据 · Benzinga

AstraZeneca Secures Dual Rare Disease and Bladder Cancer Approvals Across US, Europe

来源:Benzinga · 美国 24 分钟前
AstraZeneca Secures Dual Rare Disease and Bladder Cancer Approvals Across US, Europe
Benzinga

详细摘要

Regulators in the U.S. and European Union handed AstraZeneca Plc (NYSE:AZN) major regulatory wins across rare neuromuscular disease and oncology. The agencies cleared Klygefa for…

在 Benzinga 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.benzinga.com)

推荐阅读